THY1 and rheumatoid arthritis: Although the expanded CD34-CD90+ FLS subset in RA is considered to constitute a pathogenic phenotype, one study showed that the CD34+CD90+ FLS subset has high osteoblastic and chondrogenic potential in vitro [74].